PCRX CIK: 1396814

Pacira BioSciences, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.87
FY22:
0.50
FY23:
0.51
FY24:
0.75
FY25:
0.55
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.21
FY22:
1.18
FY23:
1.06
FY24:
0.81
FY25:
0.72
Total assets
Change from FY21 to FY25
billions USD
FY21:
2.08
FY22:
1.68
FY23:
1.57
FY24:
1.55
FY25:
1.26

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.52
FY22:
0.15
FY23:
0.10
FY24:
0.31
FY25:
0.12
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.82
FY22:
0.76
FY23:
0.61
FY24:
0.47
FY25:
0.45
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.73
FY22:
0.78
FY23:
0.87
FY24:
0.78
FY25:
0.69
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
2.08
FY22:
1.68
FY23:
1.57
FY24:
1.55
FY25:
1.26

All amounts in billions USD Data source:SEC EDGAR